Prevalence and prognostic impact of comorbidity in soft tissue sarcoma: A population-based cohort study

References

• Maretty-Nielsen K, Aggerholm-Pedersen N, Keller J, Safwat A, Baerentzen S, Pedersen A. Population-based Aarhus Sarcoma Registry: Validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark. Clin Epidemiol 2013;5:45–56.
   PubMedGoogle Scholar
• Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 2008;67:124–32.
   PubMed Web of Science ®Google Scholar
• Boje CR, Dalton SO, Gronborg TK, Primdahl H, Kristensen CA, Andersen E, et al. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: A population based study from the DAHANCA database. Acta Oncol 2013;52:285–93.
   PubMed Web of Science ®Google Scholar
• Lund L, Jacobsen J, Norgaard M, McLaughlin JK, Blot WJ, Borre M, et al. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: A Danish population based study. J Urol 2009;182:35–40.
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Costas I. The impact of comorbidity on outcomes. J Otorhinolaryngol Relat Spec 2004;66:180–5.
   PubMed Web of Science ®Google Scholar
• Lund L, Jacobsen J, Clark P, Borre M, Norgaard M. Impact of comorbidity on survival of invasive bladder cancer patients, 1996–2007: A Danish population-based cohort study. Urology 2009;75:393–8.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Grimer R, Gaston C, Francis M, Charman J, Graunt P, et al. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Eur J Cancer 2013;49:377–85.
   PubMed Web of Science ®Google Scholar
• Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States. Cancer 2009;115:2744–54.
   PubMed Web of Science ®Google Scholar
• Statbank Denmark. StatBank Denmark. [cited 2012 Jun 15]. Available from: http://statbank.dk/statbank5a/default.asp?w = 1280.
   Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health 2011;39(7 Suppl):22–5.
   PubMed Web of Science ®Google Scholar
• Danish Health and Medicines Authority. Cancer Pathways, soft tissue and bone sarcoma. [cited 2013 May 24]. Available from: http://www.sst.dk/publ/Publ2012/06juni/KraeftPkforl/SarkomerKnogleBloeddele3udg.pdf.
   Google Scholar
• Co-operative Cancer Departments. Treatment of sarcoma and aggressive benign tumors. [cited 2013 May 24]. Available from: http://www.ambkir.dk/Faglige%20retningslinier/Behandling%20af%20sarkomer.pdf.
   Google Scholar
• Jensen OM, Hogh J, Ostgaard SE, Nordentoft AM, Sneppen O. Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases. J Pathol 1991;163:19–24.
   PubMed Web of Science ®Google Scholar
• Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;(153):106–20.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl): 30–3.
   PubMed Web of Science ®Google Scholar
• Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001;164:33–7.
   PubMedGoogle Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011;39(7 Suppl):26–9.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373–83.
   PubMedGoogle Scholar
• Tetsche MS, Norgaard M, Skriver MV, Andersen ES, Lash TL, Sorensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol 2005;26:266–70.
   PubMed Web of Science ®Google Scholar
• Royston P, Sauerbrei W. Multivariable modeling with cubic regression splines: A principled approach. Stata J 2007;7:45–70.
   Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11:83–8.
   PubMed Web of Science ®Google Scholar
• Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study. BMC Cancer 2008;8:31.
   PubMed Web of Science ®Google Scholar
• Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: Does it exist?Med Care 2006; 44:745–53.
   PubMed Web of Science ®Google Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56:221–9.
   PubMed Web of Science ®Google Scholar
• van Herk-Sukel MP, Shantakumar S, Overbeek LI, van Boven H, Penning-van Beest FJ, Herings RM. Occurrence of comorbidities before and after soft tissue sarcoma diagnosis. Sarcoma 2012;2012:1–7.
   Google Scholar